The pharmaceutical manufacturer behind a batch of intravenous liquids linked to 18 cases of blood poisoning in babies, has said it is still using the same ingredient in new batches, from the same supplier.
An ITH Pharma spokesman added they are not still using the same batch of products that is believed to be affected while the batches are created to order, for a single day's use and have a seven-day shelf life.
ITH Pharma is inspected every three to five years. It passed its last inspection which took place in April 2012, the spokesman said. They also claimed that its workers undergo a "rigorous and continuous" training programme, recognised by the MHRA, which is led by an in-house team.